Exchange: OTC·Updated 01:50 PM EDT

IDRSF Idorsia Ltd

$6.24
$0.01
(0.16%)
Today
EarningsOct 29
Mkt Cap$1.68B
Vol400.00

About IDRSF

Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.
50

Neutral Sentiment

How do you feel about IDRSF?

Advertisement|Remove ads.